Skip to Main Content
Table 1

Comparison between expression of CXCR4 proteins and clinicopathological features in pancreatic ductal adenocarcinomas

No. of patientsNegative staining for CXCR4Positive staining for CXCR4p2 test)
Total 52 15 37 (71.2%)  
Primary tumor     
Limited to the pancreas (pT,2a21 16 (76.2%)  
Extend out of the pancreas (pT3,4a31 10 21 (70.0%) 0.506 
Lymph node metastasis     
Negative 18 11 (61.1%)  
Positive 34 26 (76.5%) 0.250 
Metastasis to liver     
Negative 48 15 33 (68.9%)  
Positive 4 (100%) 0.091 
Stage (UICCa    
5 (62.5%)  
II 3 (60.0%)  
III 20 14 (70.0%)  
IVa, b 19 15 (78.9%) 0.759 
No. of patientsNegative staining for CXCR4Positive staining for CXCR4p2 test)
Total 52 15 37 (71.2%)  
Primary tumor     
Limited to the pancreas (pT,2a21 16 (76.2%)  
Extend out of the pancreas (pT3,4a31 10 21 (70.0%) 0.506 
Lymph node metastasis     
Negative 18 11 (61.1%)  
Positive 34 26 (76.5%) 0.250 
Metastasis to liver     
Negative 48 15 33 (68.9%)  
Positive 4 (100%) 0.091 
Stage (UICCa    
5 (62.5%)  
II 3 (60.0%)  
III 20 14 (70.0%)  
IVa, b 19 15 (78.9%) 0.759 
a

UICC TNM Classification Ed. 5. Berlin:Springer-Verlag, 1977.

Close Modal

or Create an Account

Close Modal
Close Modal